Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

December 31, 2012

Conditions

Erosive Gastritis

Interventions

DRUG

Placebo

Dosage

DRUG

SK-MS10

Dosage

DRUG

SK-MS10

Dosage

Trial Locations (1)

SKChemicals, Seoul

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT01578811 - Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis | Biotech Hunter | Biotech Hunter